Scientific News Boston Scientific Corporation Bsx Gains 44 Ytd As Farapulse Launch Drives 17 Q2 Growth
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific Corporation Bsx Gains 44 Ytd As Farapulse Launch Drives 17 Q2 Growth is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific Delivers Robust Q3 Despite Tariff Headwinds: Analyst
Boston Scientific posts $5.07 billion in Q3 revenue, beats earnings estimates, sees WATCHMAN growth at 35%, and raises 2025 sales forecast. Read More
Boston Scientific (BSX) Fell Amid Rising Competition
Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional ... Read More
Boston Scientific Corporation (BSX) Q3 2025 Earnings Call Transcript
Good morning, and welcome to the Boston Scientific Third Quarter 2025 Earnings Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to ... Read More
Boston Scientific Gains Momentum As Growth Broadens, Goldman Sachs Says
Goldman Sachs analyst David Roman reiterated a Buy rating and $120 price target for Boston Scientific after strong Q3 results and raised guidance. Read More
Boston Scientific lifts annual profit forecast on strong demand for heart devices
Boston Scientific raised its annual profit forecast on Wednesday, after beating third-quarter profit estimates on strong demand for its heart devices, sending its shares up 4. The company's heart ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus